NasdaqGM - Nasdaq Real Time Price USD

(AAPG)

Compare
17.60
+0.27
+(1.56%)
At close: January 30 at 4:00:02 PM EST
18.00
+0.40
+(2.27%)
Pre-Market: 4:40:39 AM EST
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
903,029.00
221,984.00
209,711.00
27,910.00
12,450.00
Cost of Revenue
27,448.00
30,543.00
21,998.00
3,328.00
1,966.00
Gross Profit
875,581.00
191,441.00
187,713.00
24,582.00
10,484.00
Operating Expense
1,201,113.00
1,064,077.00
1,037,523.00
894,417.00
674,425.00
Operating Income
-325,532.00
-872,636.00
-849,810.00
-869,835.00
-663,941.00
Net Non Operating Interest Income Expense
-41,684.00
-63,648.00
-43,058.00
-9,625.00
-1,037.00
Pretax Income
-370,364.00
-932,862.00
-887,172.00
-832,249.00
-675,448.00
Tax Provision
-9,827.00
-7,150.00
-4,248.00
-49,825.00
2,158.00
Net Income Common Stockholders
-360,285.00
-925,637.00
-882,924.00
-782,424.00
-677,606.00
Diluted NI Available to Com Stockholders
-360,285.00
-925,637.00
-882,924.00
-782,424.00
-677,606.00
Total Expenses
1,228,561.00
1,094,620.00
1,059,521.00
897,745.00
676,391.00
Net Income from Continuing & Discontinued Operation
-360,285.00
-925,637.00
-882,924.00
-782,424.00
-677,606.00
Normalized Income
-359,608.44
-927,746.98
-894,602.32
-839,459.44
-674,797.25
Interest Income
35,730.00
32,409.00
9,727.00
7,106.00
5,218.00
Interest Expense
77,414.00
96,057.00
52,785.00
16,731.00
6,255.00
Net Interest Income
-41,684.00
-63,648.00
-43,058.00
-9,625.00
-1,037.00
EBIT
-292,950.00
-836,805.00
-834,387.00
-815,518.00
-669,193.00
EBITDA
-292,950.00
-743,610.00
-771,472.00
-787,192.00
-641,771.00
Reconciled Cost of Revenue
27,448.00
30,543.00
21,998.00
3,328.00
1,966.00
Reconciled Depreciation
--
93,195.00
62,915.00
28,326.00
27,422.00
Net Income from Continuing Operation Net Minority Interest
-360,285.00
-925,637.00
-882,924.00
-782,424.00
-677,606.00
Total Unusual Items Excluding Goodwill
-695.00
2,127.00
11,737.00
60,676.00
-3,745.00
Total Unusual Items
-695.00
2,127.00
11,737.00
60,676.00
-3,745.00
Normalized EBITDA
-292,255.00
-745,737.00
-783,209.00
-847,868.00
-638,026.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-18.44
17.02
58.69
3,640.56
-936.25
12/31/2020 - 1/24/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UPB Upstream Bio, Inc.
11.00
+7.32%
 
IZTC Invizyne Technologies, Inc.
17.40
+9.37%
 
MAR.F Maravai LifeSciences Holdings, Inc.
4.8000
+0.84%
 
2157.HK Lepu Biopharma Co., Ltd.
2.730
-4.88%
 
2162.HK Keymed Biosciences Inc.
29.500
-2.48%
 
2257.HK Sirnaomics Ltd.
2.890
+4.33%
 
2142.HK HBM Holdings Limited
3.660
+3.68%
 
1672.HK ASCLETIS-B
4.050
-0.74%
 
OCEAW Ocean Biomedical, Inc.
0.0329
-15.64%
 
BLTE Belite Bio, Inc
59.60
+3.83%